These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38427723)
1. Synthesis of Indole-Linked Thiadiazoles and their Anticancer Action against Triple-Negative Breast Cancer. Gavadia R; Rasgania J; Sahu N; Nimesh S; Loveleen L; Mor S; Jakhar K Chem Biodivers; 2024 Apr; 21(4):e202302000. PubMed ID: 38427723 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and docking studies of novel 4-aminophenol-1,2,4-oxadiazole hybrids as apoptosis inducers against triple negative breast cancer cells targeting MAP kinase. Dhanalakshmi B; Anil Kumar BM; Srinivasa Murthy V; Srinivasa SM; Vivek HK; Sennappan M; Rangappa S J Biomol Struct Dyn; 2024 Jul; 42(11):5841-5857. PubMed ID: 37529915 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines. Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline Derivatives as Potent Anticancer Agents against Triple-negative Breast Cancer. Kaushal T; Khan S; Fatima K; Luqman S; Khan F; Negi AS Curr Top Med Chem; 2022; 22(10):855-867. PubMed ID: 35331094 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of thiadiazolo-carboxamide bridged β-carboline-indole hybrids: DNA intercalative topo-IIα inhibition with promising antiproliferative activity. Tokala R; Sana S; Lakshmi UJ; Sankarana P; Sigalapalli DK; Gadewal N; Kode J; Shankaraiah N Bioorg Chem; 2020 Dec; 105():104357. PubMed ID: 33091673 [TBL] [Abstract][Full Text] [Related]
6. Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway. Xu X; Rajamanickam V; Shu S; Liu Z; Yan T; He J; Liu Z; Guo G; Liang G; Wang Y Drug Des Devel Ther; 2019; 13():3539-3550. PubMed ID: 31631978 [TBL] [Abstract][Full Text] [Related]
7. Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential. Kamath PR; Sunil D; Joseph MM; Abdul Salam AA; T T S Eur J Med Chem; 2017 Aug; 136():442-451. PubMed ID: 28525842 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors. Al-Warhi T; El Kerdawy AM; Aljaeed N; Ismael OE; Ayyad RR; Eldehna WM; Abdel-Aziz HA; Al-Ansary GH Molecules; 2020 Apr; 25(9):. PubMed ID: 32349307 [TBL] [Abstract][Full Text] [Related]
9. 5-(Thiophen-2-yl)-1,3,4-thiadiazole derivatives: synthesis, molecular docking and in vitro cytotoxicity evaluation as potential anticancer agents. Gomha SM; Edrees MM; Muhammad ZA; El-Reedy AA Drug Des Devel Ther; 2018; 12():1511-1523. PubMed ID: 29881258 [TBL] [Abstract][Full Text] [Related]
10. Mechanochemical Synthesis and Molecular Docking Studies of New Azines Bearing Indole as Anticancer Agents. Ibrahim MS; Farag B; Al-Humaidi JY; Zaki MEA; Fathalla M; Gomha SM Molecules; 2023 May; 28(9):. PubMed ID: 37175279 [TBL] [Abstract][Full Text] [Related]
11. Ultrasound Promoted Green Synthesis, Docking Study of Indole Spliced Thiadiazole, α-amino Phosphonates as Anticancer Agents and Antityrosinase Agents. Nikalje AG; Gawhane PA; Tiwari SV; Sangshetti JN; Damale MG Anticancer Agents Med Chem; 2018; 18(9):1267-1280. PubMed ID: 29667556 [TBL] [Abstract][Full Text] [Related]
13. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors. Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties. Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492 [TBL] [Abstract][Full Text] [Related]
15. Chemical Characterization, Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, Molecular Docking Screening and Anti-Proliferative Potency Evaluation of Some New Imidazo[2,1- Rashdan HRM; Abdelmonsef AH; Shehadi IA; Gomha SM; Soliman AMM; Mahmoud HK Molecules; 2020 Oct; 25(21):. PubMed ID: 33126630 [TBL] [Abstract][Full Text] [Related]
17. Benzo[ Guerra FS; Dias FRF; Cunha AC; Fernandes PD Molecules; 2021 Jul; 26(15):. PubMed ID: 34361566 [TBL] [Abstract][Full Text] [Related]
18. Development of adamantane scaffold containing 1,3,4-thiadiazole derivatives: Design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR. Wassel MMS; Ammar YA; Elhag Ali GAM; Belal A; Mehany ABM; Ragab A Bioorg Chem; 2021 May; 110():104794. PubMed ID: 33735711 [TBL] [Abstract][Full Text] [Related]
19. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation. Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents. Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]